Information technologySeattle cancer therapy firm sees promise in Boston biotech firm | Boston Business Journal
Seattle-based Juno Therapeutics, which develops immunotherapies for cancer treatment, purchased Boston's RedoxTherapies for $10 million, with additional payments for undisclosed milestones. Founded by Northeastern University professor Michail Sitkovsky, RedoxTherapies created a compound that may help the immune systems of those with cancer better fight the disease.
Medical devices and equipmentFDA approve remote breathalyzer for clinical use | Medscape
The U.S. Food and Drug Administration has approved a handheld device that healthcare providers can use to remotely monitor patients' alcohol intake.
PharmaceuticalsFraud concerns emerge as compounding drug sales skyrocket | Kaiser Health News
Government spending on “compounded” drugs that are handmade by retail pharmacists has skyrocketed, drawing the attention of federal investigators who are raising fraud and overbilling concerns.
Drug makers' pricing power remains strong | The Wall Street Journal
Pharmaceutical companies' power to raise prices is firmly intact despite pushback from health insurers, scrutiny by U.S. lawmakers and anxiety about rising prescription drug spending.
GlaxoSmithKline has started a rheumatoid arthritis study using Apple's ResearchKit, marking the first time a drugmaker has used the health system for the iPhone to conduct clinical research.
PhysiciansComplaints process tied to long-term psychological damage in docs | Medscape
Patient complaints against physicians and the ensuing complaint review process seriously affect physicians' long-term psychological well-being and can lead to their practicing defensive medicine, results of a large qualitative survey show.
America's pediatricians are tired of watching their patients traumatized by gun violence and racism. Now, they're launching an effort to do something about it. The American Academy of Pediatrics on Monday issued recommendations that children under 6 be shielded from on-screen violence, that video games stop awarding points for shooting living targets, and that the media avoid downplaying the proven link between virtual and real violence.